Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia

Human Psychopharmacology

Volumn 28, Issue 1, 2013, Pages 94-96

  Suzuki, Yutaro ^a   Sugai, Takuro ^a   Fukui, Naoki ^a   Watanabe, Junzo ^a   Ono, Shin ^a   Tsuneyama, Nobuto ^a   Saito, Mami ^a   Someya, Toshiyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

aripiprazole; olanzapine; quetiapine; risperidone

Indexed keywords

ARIPIPRAZOLE; MAGNESIUM; OLANZAPINE; POTASSIUM; QUETIAPINE; RISPERIDONE; SODIUM;

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; HUMAN; JAPANESE; MAGNESIUM BLOOD LEVEL; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT PROLONGATION; SCHIZOPHRENIA; SODIUM BLOOD LEVEL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DIBENZOTHIAZEPINES; DRUG SUBSTITUTION; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84873088096     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2277     Document Type: Article

References (10)

1. Glassman AH, Bigger JT Jr,. 2001. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158: 1774-1782.
2. Günther T, Schmitt AO, Bortfeldt RH, Hinney A, Hebebrand J, Brockmann GA,. 2011. Where in the genome are significant single nucleotide polymorphisms from genome-wide association studies located? OMICS 15: 507-512.
3. Haring R, Wallaschofski H,. 2012. Diving through the "-omics": the case for deep phenotyping and systems epidemiology. OMICS 16: 231-234.
4. Harrigan EP, Miceli JJ, Anziano R, et al,. 2004. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol 24: 62-69.
5. Hough DW, Natarajan J, Vandebosch A, Rossenu S, Kramer M, Eerdekens M,. 2011. Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: a randomized, double-blind, placebo-controlled study. Int Clin Psychopharmacol 26: 25-34.
6. Lieberman JA, Stroup TS, McEvoy JP, et al,. 2005. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1223.
7. Ozeki Y, Fujii K, Kurimoto N, et al,. 2010. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 34: 401-405.
8. Pigott TA, Carson WH, Saha AR, et al,. 2003. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. J Clin Psychiatry 64: 1048-1056.
9. Ray WA, Chung CP, Murray KT, Hall K, Stein CM,. 2009. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360: 225-235.
10. Suzuki Y, Sugai T, Ono S, et al,. 2011. Changes in the metabolic parameters and QTc interval after switching from olanzapine to aripiprazole in Japanese patients with stable schizophrenia. J Clin Psychopharmacol 31: 526-528.